AI-powered tool improves the detection of focal cortical dysplasia

Scientists have developed an AI-powered tool that detects 64% of brain abnormalities linked to epilepsy that human radiologists miss.

RP-3 by Replimune for Breast Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 18, 2023

Celldex says antibody drug improves irritable skin condition in Phase 2 test

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Antitachycardia Pacing Helps With Upfront Delay in ICD Shocks

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer first device shocks but perhaps at a cost, the APPRAISE ATP randomized trial

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.